Expanding at a CAGR of 7.8%, the global peptide-based cancer therapeutics market is forecasted to increase from a valuation of US$ 10.1 billion in 2023 to US$ 21.4 billion by the end of 2033. A rise in research and development activities and continuous clinical trials are presenting lucrative prospects for bortezomib drug manufacturer.
Peptide-based cancer therapeutics represent a promising...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)